Literature DB >> 21345337

Kidney impairment in primary aldosteronism.

Vin-Cent Wu1, Shao-Yu Yang, Jou-Wei Lin, Bor-Wen Cheng, Chin-Chi Kuo, Chia-Ti Tsai, Tzong-Shinn Chu, Kuo-How Huang, Shuo-Meng Wang, Yen-Hung Lin, Chih-Kang Chiang, Hung-Wei Chang, Chien-Yu Lin, Lian-Yu Lin, Jainn-Shiun Chiu, Fu-Chang Hu, Shih-Chieh Chueh, Yi-Luwn Ho, Kao-Lang Liu, Shuei-Liong Lin, Ruoh-Fang Yen, Kwan-Dun Wu.   

Abstract

BACKGROUND: Kidney impairment is noted in primary aldosteronism (PA), and probably initiated by glomerular hyperfiltration.
METHODS: A prospectively defined survey was conducted on 602 patients who were suspected of PA in the multiple-center Taiwan Primary Aldosteronism Investigation (TAIPAI) database. Estimated glomerular filtration rate (eGFR) was calculated and followed up at 1 yr after treatment.
RESULTS: The diagnosis of PA was confirmed in 330 patients. Among them 17% of these patients had kidney impairment (eGFR<60 ml/min/1.73 m²). Patients with PA had a higher prevalence of estimated hyperfiltration than those with essential hypertension (EH) (14.5% vs. 7.0%, p=0.005). The eGFR independently predicted PA (OR, 1.017) in the propensity-adjusted multivariate logistic model. In PA, plasma renin activity and lower serum potassium (p=0.018) was correlated with kidney impairment (p=0.001), while this relationship was not significant in patients with EH. Either unilateral adrenalectomy or treatment of spironolactone for PA patients caused a decrease of eGFR (p<0.001). Pre-operative hypokalemia (p=0.013) and the long latency of hypertension (p=0.016) could enhance the significant decrease of eGFR after adrenalectomy.
CONCLUSIONS: Patients with aldosteronism had relative estimated hyperfiltration than patients with EH. Calculation of eGFR may increase the specificity in identifying patients with PA. Our findings demonstrate the correlation of serum potassium and renin with estimated hyperfiltration in PA and their relationship to kidney damage. These results provide a high priority for future renal protective strategies and methods for the early diagnosis and prompt treatment of PA.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345337     DOI: 10.1016/j.cca.2011.02.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  33 in total

1.  Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.

Authors:  Takanobu Utsumi; Naoto Kamiya; Mayuko Kaga; Takumi Endo; Masashi Yano; Shuichi Kamijima; Koji Kawamura; Takashi Imamoto; Tomohiko Ichikawa; Hiroyoshi Suzuki
Journal:  World J Urol       Date:  2017-04-11       Impact factor: 4.226

2.  Change in kidney function after unilateral adrenalectomy in patients with primary aldosteronism: identification of risk factors for decreased kidney function.

Authors:  Il Young Kim; In Seong Park; Min Jeong Kim; Miyeun Han; Harin Rhee; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Sang Heon Song; Hyun Chul Chung
Journal:  Int Urol Nephrol       Date:  2018-05-19       Impact factor: 2.370

Review 3.  A systematic review of glomerular hyperfiltration assessment and definition in the medical literature.

Authors:  Francois Cachat; Christophe Combescure; Michel Cauderay; Eric Girardin; Hassib Chehade
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

4.  Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.

Authors:  Mayuko Kaga; Takanobu Utsumi; Tomoaki Tanaka; Takashi Kono; Hidekazu Nagano; Koji Kawamura; Naoto Kamiya; Takashi Imamoto; Naoki Nihei; Yukio Naya; Hiroyoshi Suzuki; Tomohiko Ichikawa
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

5.  Comparison of C-arm computed tomography and on-site quick cortisol assay for adrenal venous sampling: A retrospective study of 178 patients.

Authors:  Chin-Chen Chang; Bo-Ching Lee; Yeun-Chung Chang; Vin-Cent Wu; Kuo-How Huang; Kao-Lang Liu
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

6.  Call for screening for primary aldosteronism: an underdiagnosed and treatable disease.

Authors:  Leay Kiaw Er; Vin-Cent Wu
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

7.  Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study.

Authors:  María Fernández-Argüeso; Eider Pascual-Corrales; Nuria Bengoa Rojano; Ana García Cano; Lucía Jiménez Mendiguchía; Marta Araujo-Castro
Journal:  Endocrine       Date:  2021-04-02       Impact factor: 3.633

Review 8.  Left ventricular remodeling and dysfunction in primary aldosteronism.

Authors:  Cheng-Hsuan Tsai; Chien-Ting Pan; Yi-Yao Chang; Zheng-Wei Chen; Vin-Cent Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Hum Hypertens       Date:  2020-10-16       Impact factor: 3.012

9.  Comparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronism.

Authors:  Che-Hsiung Wu; Ya-Wen Yang; Ya-Hui Hu; Yao-Chou Tsai; Ko-Lin Kuo; Yen-Hung Lin; Szu-Chun Hung; Vin-Cent Wu; Kwan-Dun Wu
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

10.  Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.

Authors:  Kuan-Ming Chen; Bo-Ching Lee; Po-Ting Chen; Kao-Lang Liu; Kuan-Heng Lin; Chin-Chen Chang; Tung-Hsin Wu; Jia-Sheng Hong; Yen-Hung Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.